Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Disease Reports
postcoital contraception
MeSH D044363 - postcoital contraception
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D003267:
Contraception
3 Companies
4 Drugs
$
Success rate
D044363:
Postcoital contraception
1 Company
1 Drug
$
Success rate
Events Timeline
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
HRA Pharma
Ulipristal
ellaOne
2009-05-15
Clinical Trials
Historical Success Rate
Phase 1
50
%
2/4
Phase 2
100
%
3/3
Phase 3
75
%
3/4
Approved:
1
Overall Success rate:
38%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
HRA Pharma
Ulipristal acetate
,
Ulipristal
,
Va2914
,
Microgynon
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use